Back to search
Multiple Sclerosis, Optic Neuritis, Demyelinating Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multiple Sclerosis, Optic Neuritis, Demyelinating Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Multiple Sclerosis, Optic Neuritis, Demyelinating Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (O…
Neurological autoimmune diseases are a group of disorders characterized by the abnormal immune response attacking the nervous system, including the brain, spina…
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).
Neuroimmune diseases are more prevalent among women of reproductive age. Studies have shown that neuroimmune diseases may impact fertility. Therefore, effective…
In this protocol, a combination of MRI, blood, and cerebrospinal fluid (CSF) analysis will be used to understand the natural history, underlying immunologic mec…
CLUE is a prospective study to assess structural and functional changes of the brain, spinal cord, and optic nerve, as well as the inflammatory environment in p…
The goal of this observational study is to determine whether genetic information, together with clinical information, can be used to improve prediction of futur…
This is an investigator-initiated, single-center, open-label study of C-CAR168, an autologous bi-specific CAR-T therapy targeting CD20 and BCMA, for the treatme…